NCT07085338
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07085338
Title A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications
Therapies
Age Groups: child | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco NOT_YET_RECRUITING San Francisco California 94158 United States Details
Children's Hospital of Colorado NOT_YET_RECRUITING Colorado Springs Colorado 80902 United States Details
Motts Childrens Hospital NOT_YET_RECRUITING Ann Arbor Michigan 48109 United States Details
St. Jude Children's Research Hospital RECRUITING Memphis Tennessee 38105 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field